Skip to content
Subscriber Only

Glucosamine Shows No Benefit for Back Pain Patients in Study

Taking the nutritional supplement glucosamine provided no significant benefit to arthritis patients with chronic lower back pain, according to the first large, long-term study of its kind.

In the trial, conducted at Oslo University Hospital in Norway, 125 patients took 1,500 milligrams of glucosamine and 125 took placebo pills daily for six months. The researchers found no significant differences and no reduction in pain-related disability between the two groups during the study and after one year, according to the results, to be published tomorrow in the Journal of the American Medical Association.